Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Localization, Management, Resource Consumption and Outcome of Major Gastrointestinal Bleeding in Patients with Direct Oral Anticoagulants, Vka and Antiplatelet Therapy

Sven Pannach, MD, Julia Goetze, Luise Tittl, B.Sc., Thomas Schreier, Sandra Marten, MD, Jochen Hampe, MD, Jan Beyer-Westendorf, MD

Blood (2016) 128 (22): 141.

https://doi.org/10.1182/blood.V128.22.141.141

Published: 2016

Journal Articles

Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – Final Results of the Prospective Noac Registry (NCT01588119)

Franziska Ebertz, Sebastian Werth, MD, Christina Köhler, MD, Franziska Michalski, Ulrike Hänsel, Luise Tittl, Katharina Daschkow, Thomas Schreier, Jan Beyer-Westendorf, MD

Blood (2014) 124 (21): 1541.

https://doi.org/10.1182/blood.V124.21.1541.1541

Published: 2014

Journal Articles

Real Life Efficacy and Safety of Rivaroxaban for Stroke Prevention in Atrial Fibrillation – First Results of the Prospective Noac Registry (NCT01588119)

Sebastian Werth, MD, Christina Koehler, Vera Gelbricht, Ulrike Haensel, Luise Tittl, Ines Beyer-Westendorf, Thomas Schreier, Jan Beyer-Westendorf, MD

Blood (2012) 120 (21): 1156.

https://doi.org/10.1182/blood.V120.21.1156.1156

Published: 2012

Journal Articles

Real Life Efficacy and Safety of Rivaroxaban for Acute VTE Treatment – First Results of the Prospective Noac Registry (NCT01588119)

Vera Gelbricht, Christina Koehler, Sebastian Werth, MD, Ulrike Haensel, Thomas Schreier, Maria Eulitz, Luise Tittl, Ines Beyer-Westendorf, Jan Beyer-Westendorf, MD

Blood (2012) 120 (21): 1159.

https://doi.org/10.1182/blood.V120.21.1159.1159

Published: 2012

Journal Articles

Real Life Efficacy and Safety of Rivaroxaban for Extended VTE Treatment – First Results of the Prospective Noac Registry (NCT01588119).

Christina Koehler, Sebastian Werth, MD, Vera Gelbricht, Ulrike Haensel, Luise Tittl, Ines Beyer-Westendorf, Thomas Schreier, Maria Eulitz, Jan Beyer-Westendorf, MD

Blood (2012) 120 (21): 2267.

https://doi.org/10.1182/blood.V120.21.2267.2267

Published: 2012

Journal Articles

Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – First Results of the Prospective Noac Registry (NCT01588119)

Vera Gelbricht, Sebastian Werth, MD, Christina Koehler, Ulrike Haensel, Luise Tittl, Ines Beyer-Westendorf, Thomas Schreier, Jan Beyer-Westendorf, MD

Blood (2012) 120 (21): 502.

https://doi.org/10.1182/blood.V120.21.502.502

Published: 2012

Journal Articles

Hair Loss Is a Potential Side Effect of Novel Oral Anticoagulants – Findings From the Dresden Noac Registry (NCT01588119)

Vera Gelbricht, Christina Koehler, Sebastian Werth, MD, Ulrike Haensel, Thomas Schreier, Tittl Luise, Maria Eulitz, Ines Beyer-Westendorf, Jan Beyer-Westendorf, MD

Blood (2012) 120 (21): 1173.

https://doi.org/10.1182/blood.V120.21.1173.1173

Published: 2012

NARROW

Localization, Management, Resource Consumption and Outcome of Major Gastrointestinal Bleeding in Patients with Direct Oral Anticoagulants, Vka and Antiplatelet Therapy

Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – Final Results of the Prospective Noac Registry (NCT01588119)

Real Life Efficacy and Safety of Rivaroxaban for Stroke Prevention in Atrial Fibrillation – First Results of the Prospective Noac Registry (NCT01588119)

Real Life Efficacy and Safety of Rivaroxaban for Acute VTE Treatment – First Results of the Prospective Noac Registry (NCT01588119)

Real Life Efficacy and Safety of Rivaroxaban for Extended VTE Treatment – First Results of the Prospective Noac Registry (NCT01588119).

Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – First Results of the Prospective Noac Registry (NCT01588119)

Hair Loss Is a Potential Side Effect of Novel Oral Anticoagulants – Findings From the Dresden Noac Registry (NCT01588119)

Email alerts

ASH Publications

American Society of Hematology

Localization, Management, Resource Consumption and Outcome of Major Gastrointestinal Bleeding in Patients with Direct Oral Anticoagulants, Vka and Antiplatelet Therapy

Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – Final Results of the Prospective Noac Registry (NCT01588119)

Real Life Efficacy and Safety of Rivaroxaban for Stroke Prevention in Atrial Fibrillation – First Results of the Prospective Noac Registry (NCT01588119)

Real Life Efficacy and Safety of Rivaroxaban for Acute VTE Treatment – First Results of the Prospective Noac Registry (NCT01588119)

Real Life Efficacy and Safety of Rivaroxaban for Extended VTE Treatment – First Results of the Prospective Noac Registry (NCT01588119).

Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – First Results of the Prospective Noac Registry (NCT01588119)

Hair Loss Is a Potential Side Effect of Novel Oral Anticoagulants – Findings From the Dresden Noac Registry (NCT01588119)

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only